tiprankstipranks
Trending News
More News >
BioStem Technologies (BSEM)
:BSEM
US Market

BioStem Technologies (BSEM) Income Statement

Compare
245 Followers

BioStem Technologies Income Statement

Last quarter (Q2 2025), BioStem Technologies's total revenue was $49.30M, a decrease of -33.82% from the same quarter last year. In Q2, BioStem Technologies's net income was $-564.36K. See BioStem Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 301.83M$ 16.69M$ 6.88M$ 4.34M$ 2.52M
Gross Profit
$ 287.86M$ 15.42M$ 5.99M$ 2.87M$ 1.25M
Operating Expenses
$ 256.66M$ 23.20M$ 10.67M$ 4.47M$ 3.09M
Depreciation and Amortization
$ 293.22K$ 229.02K$ 243.42K$ 283.90K$ 268.58K
EBITDA
$ 31.49M$ -7.55M$ -6.52M$ -602.00K$ -2.25M
Operating Income
$ 31.20M$ -7.78M$ -4.68M$ -1.61M$ -1.84M
Other Income/Expenses
$ -587.22K$ -704.01K$ -2.55M$ 193.93K$ -526.97K
Pretax Income
$ 30.61M$ -8.48M$ -7.11M$ -1.41M$ -2.37M
Net Income
$ 31.88M$ -8.48M$ -7.07M$ -1.45M$ -2.39M
Per Share Metrics
Basic EPS
$ 1.95$ -0.62$ -0.62$ -0.12$ -0.26
Diluted EPS
$ 1.47$ -0.62$ -0.62$ -0.12$ -0.26
Weighted Average Shares Outstanding
16.37M 13.71M 11.41M 11.69M 9.18M
Weighted Average Shares Outstanding (Diluted)
21.70M 13.71M 11.41M 11.69M 9.18M
Currency in USD

BioStem Technologies Earnings and Revenue History